Resultado da Busca
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
17 de fev. de 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner and the former Acting Commissioner of Food and Drugs. She has led the agency’s drug evaluation and approval, biologics research, and COVID-19 response, and received many honors for her public health career.
- Principal Deputy Commissioner
- Office of The Commissioner
16 de nov. de 2023 · WASHINGTON, Nov 16 (Reuters) - U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as...
16 de nov. de 2023 · Woodcock, a 37-year veteran of the FDA, was acting commissioner at the beginning of the Biden administration and a key decision-maker on controversial drugs and COVID-19 response. She will leave the agency after facing criticism for approving opioids, Alzheimer’s and muscular dystrophy drugs.
4 de mar. de 2021 · Now, under a new administration, the FDA has a new interim leader, Dr. Janet Woodcock. She's acting commissioner of the FDA, and she's here now. Welcome. JANET WOODCOCK: Thank you. KELLY: I...
16 de nov. de 2023 · US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven...
30 de jan. de 2024 · Janet Woodcock, the FDA's principal deputy commissioner, reflects on her more than 30 years at the agency and hints at what's next. She oversaw hundreds of drug reviews, faced Covid-19 challenges and a reorganization plan.
